Skip to main content

Use of anticoagulation and D-dimer levels in patients with acute heart failure

Introduction

Decompensated heart failure (DHF) is associated with several coagulation disturbances, including elevation of the circulating D-dimer levels, contributing to pathophysiology and thromboembolic events. The influence of oral anticoagulant on D-dimer levels in patients with HF has not been established.

Objective

To verify whether oral anticoagulant treatment would influence D-dimer levels in patients with DHF.

Materials and methods

A cohort study with 70 patients admitted with DHF (85.7% NYHA FC IV) to the coronary care unit during 1 year. Of this sample, 53 patients had a D-dimer dosage on admission and were divided into two groups: group A (GA = 8 patients) with oral anticoagulant; and group B (GB = 45 patients) without oral anticoagulant. The Student t test was performed for the analysis.

Results

GA and GB were similar with respect to mean age (78.7 ± 11.8 vs 77.0 ± 10.1 years) and male gender (37.5% vs 57.7%). The mean INR (GA) was 4.09 ± 2.61. There was no difference in admissional D-dimer levels between GA and GB (GA = 1326.5 mg/dl vs GB = 1426.2 mg/dl, P = 0.81).

Conclusions

This study indicated that oral anticoagulant therapy did not influence circulating D-dimer levels, despite adequate anticoagulation, suggesting that this therapy does not completely protect against all coagulation abnormalities observed in DHF.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bittencourt, M., Rocha, R., Rey, H. et al. Use of anticoagulation and D-dimer levels in patients with acute heart failure. Crit Care 9 (Suppl 2), P32 (2005). https://doi.org/10.1186/cc3576

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/cc3576

Keywords